These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38140900)

  • 21. Plexiform neurofibroma of the tongue: a case report of a child.
    Güneri EA; Akoğlu E; Sütay S; Ceryan K; Sağol O; Pabuçcuoğlu U
    Turk J Pediatr; 2006; 48(2):155-8. PubMed ID: 16848118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas.
    Dombi E; Baldwin A; Marcus LJ; Fisher MJ; Weiss B; Kim A; Whitcomb P; Martin S; Aschbacher-Smith LE; Rizvi TA; Wu J; Ershler R; Wolters P; Therrien J; Glod J; Belasco JB; Schorry E; Brofferio A; Starosta AJ; Gillespie A; Doyle AL; Ratner N; Widemann BC
    N Engl J Med; 2016 Dec; 375(26):2550-2560. PubMed ID: 28029918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perspectives of adults with neurofibromatosis regarding the design of psychosocial trials: Results from an anonymous online survey.
    Wolters PL; Ghriwati NA; Baker M; Martin S; Berg D; Erickson G; Franklin B; Merker VL; Oberlander B; Reeve S; Rohl C; Rosser T; Vranceanu AM
    Clin Trials; 2024 Feb; 21(1):73-84. PubMed ID: 37962219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orbital/Periorbital Plexiform Neurofibromas in Children with Neurofibromatosis Type 1: Multidisciplinary Recommendations for Care.
    Avery RA; Katowitz JA; Fisher MJ; Heidary G; Dombi E; Packer RJ; Widemann BC;
    Ophthalmology; 2017 Jan; 124(1):123-132. PubMed ID: 27817916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plexiform neurofibroma: shedding light on the investigational agents in clinical trials.
    Acar S; Armstrong AE; Hirbe AC
    Expert Opin Investig Drugs; 2022 Jan; 31(1):31-40. PubMed ID: 34932916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perspectives of adolescents with neurofibromatosis 1 and cutaneous neurofibromas: Implications for clinical trials.
    Cannon A; Sarin KY; Petersen AK; Pichard DC; Wolters PL; Erickson G; Lessing AJ; Li P; Röhl C; Rosser T; Widemann BC; Blakeley JO; Plotkin SR
    Clin Trials; 2024 Feb; 21(1):67-72. PubMed ID: 37269078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Review of Selumetinib in the Treatment of Neurofibromatosis Type 1-Related Plexiform Neurofibromas.
    Anderson MK; Johnson M; Thornburg L; Halford Z
    Ann Pharmacother; 2022 Jun; 56(6):716-726. PubMed ID: 34541874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pain interference in youth with neurofibromatosis type 1 and plexiform neurofibromas and relation to disease severity, social-emotional functioning, and quality of life.
    Wolters PL; Burns KM; Martin S; Baldwin A; Dombi E; Toledo-Tamula MA; Dudley WN; Gillespie A; Widemann BC
    Am J Med Genet A; 2015 Sep; 167A(9):2103-13. PubMed ID: 25976979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential endpoints for assessment of bone health in persons with neurofibromatosis type 1.
    Gross AM; Plotkin SR; Watts NB; Fisher MJ; Klesse LJ; Lessing AJ; McManus ML; Larson AN; Oberlander B; Rios JJ; Sarnoff H; Simpson BN; Ullrich NJ; Stevenson DA
    Clin Trials; 2024 Feb; 21(1):29-39. PubMed ID: 37772407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient Report of Hearing in Neurofibromatosis Type 2: Recommendations for Clinical Trials.
    Thompson HL; Blanton A; Franklin B; Merker VL; Franck KH; Welling DB;
    Neurology; 2021 Aug; 97(7 Suppl 1):S64-S72. PubMed ID: 34230203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas.
    Kim A; Gillespie A; Dombi E; Goodwin A; Goodspeed W; Fox E; Balis FM; Widemann BC
    Neurology; 2009 Oct; 73(16):1273-9. PubMed ID: 19841379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recommendations for the collection and annotation of biosamples for analysis of biomarkers in neurofibromatosis and schwannomatosis clinical trials.
    Sundby RT; Rhodes SD; Komlodi-Pasztor E; Sarnoff H; Grasso V; Upadhyaya M; Kim A; Evans DG; Blakeley JO; Hanemann CO; Bettegowda C
    Clin Trials; 2024 Feb; 21(1):40-50. PubMed ID: 37904489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Rare form of a segmental neurofibromatosis with giant plexiform neurofibroma].
    Reschke R; Kadlecova M; Grunewald S; Ziemer M
    Hautarzt; 2019 Aug; 70(8):638-640. PubMed ID: 31076816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative associations of scalp and body subcutaneous neurofibromas with internal plexiform tumors in neurofibromatosis 1.
    Jett K; Nguyen R; Arman D; Birch P; Chohan H; Farschtschi S; Fuensterer C; Kluwe L; Friedman JM; Mautner VF
    Am J Med Genet A; 2015 Jul; 167(7):1518-24. PubMed ID: 25900062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth behavior of plexiform neurofibromas after surgery.
    Nguyen R; Ibrahim C; Friedrich RE; Westphal M; Schuhmann M; Mautner VF
    Genet Med; 2013 Sep; 15(9):691-7. PubMed ID: 23598713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas.
    Gross AM; Dombi E; Wolters PL; Baldwin A; Dufek A; Herrera K; Martin S; Derdak J; Heisey KS; Whitcomb PM; Steinberg SM; Venzon DJ; Fisher MJ; Kim A; Bornhorst M; Weiss BD; Blakeley JO; Smith MA; Widemann BC
    Neuro Oncol; 2023 Oct; 25(10):1883-1894. PubMed ID: 37115514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plexiform Neurofibroma Without Neurofibromatosis Type 1.
    Wollina U; Schönlebe J
    Acta Dermatovenerol Croat; 2020 Dec; 28(7):245-246. PubMed ID: 33835000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ten-Year Follow-up of Internal Neurofibroma Growth Behavior in Adult Patients With Neurofibromatosis Type 1 Using Whole-Body MRI.
    Ly KI; Merker VL; Cai W; Bredella MA; Muzikansky A; Thalheimer RD; Da JL; Orr CC; Herr HP; Morris ME; Chang CY; Harris GJ; Plotkin SR; Jordan JT
    Neurology; 2023 Feb; 100(7):e661-e670. PubMed ID: 36332985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lifespan Development: Symptoms Experienced by Individuals with Neurofibromatosis Type 1 Associated Plexiform Neurofibromas from Childhood into Adulthood.
    Jensen SE; Patel ZS; Listernick R; Charrow J; Lai JS
    J Clin Psychol Med Settings; 2019 Sep; 26(3):259-270. PubMed ID: 30298332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plexiform neurofibromas.
    Korf BR
    Am J Med Genet; 1999 Mar; 89(1):31-7. PubMed ID: 10469434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.